June 30, 2025
The information on this site is not intended to take the place of your doctor or other healthcare professionals. It is a resource to help you make the best decisions and get the most from the medical services available to you. A licensed physician should be consulted for diagnosis and treatment of all medical conditions.
On June 17, 2025, B. Braun Medical Inc. issued a recall for 0.9% (Sodium Chloride) NACL INJ USP 500mL due to potential fluid leakage from small pinholes in the IV bags. The FDA-approved use for 0.9% NACL INJ USP 500mL is for IV administration to provide fluid and electrolyte replenishment, and it can also be used to prepare other sterile drugs, including chemotherapy and other hazardous drugs. The leakage may pose risks such as falls, slips, treatment delays, exposure to hazardous drugs, and potential bloodstream infections, particularly in vulnerable patients. For more information about the recall, see here.
Last updated: June 30, 2025